Rituximab (2 x 1000 mg) plus methotrexate vs methotrexate
Discontinuation of medication due to adverse events · patients with rheumatoid arthritis
Rituximab (2 x 1000 mg) plus methotrexate showed no clear difference in discontinuations due to adverse events Analysis 6.3 compared with methotrexate monotherapy (moderate certainty).
1 finding from 1 review
- RR 2.1 [0.88, 4.9]5 studies · 1385 participantsModerate